1 |
Braddock M. Tissue repair and ulcer/wound healing-Institut Pasteur Euroconference: molecular mechanisms, therapeutic targets and future directions. IDrugs 2005;8:381-3.
|
2 |
Kirsner RS, Bohn G, Driver VR, et al. Human acellular dermal wound matrix: evidence and experience. Int Wound J 2015;12:646-54.
DOI
|
3 |
Cazzell S, Vayser D, Pham H, et al. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator. Wound Repair Regen 2017;25:483-97.
DOI
|
4 |
Martin BR, Sangalang M, Wu S, et al. Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds:an initial experience. Int Wound J 2005;2:161-5.
DOI
|
5 |
Jang HJ, Kim YM, Yoo BY, et al. Wound-healing effects of human dermal components with gelatin dressing. J Biomater Appl 2018;32:716-24.
DOI
|
6 |
Green T, Kavros S, Springer S, et al. Team approach: complex dermal wound-healing utilizing negative-pressure wound therapy (NPWT) in orthopaedic trauma. JBJS Rev 2018;6:e1.
|
7 |
Jeffery S, Leaper D, Armstrong D, et al. Using negative pressure wound therapy to prevent surgical site infection. J Wound Care 2018;27(Suppl 3):S5-13.
DOI
|
8 |
Choi JY, Kim SH, Oh GJ, et al. Management of defects on lower extremities with the use of matriderm and skin graft. Arch Plast Surg 2014;41:337-43.
DOI
|
9 |
Brigido SA. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J 2006;3:181-7.
DOI
|